The National Health Commission issued a notice regulating the naming of outpatient departments at medical institutions, emphasizing that names should be lawful, standardized, clear, and accurate, and should not imply therapeutic effects in a misleading way.

The National Healthcare Security Administration also released information on the 11th round of centralized drug procurement, with 480 pharmaceutical companies participating under policy requirements focused on clinical stability, quality assurance, anti-collusion, and orderly competition.

The Supreme People's Court disclosed typical cases related to insurance fraud, reminding the industry to strengthen compliance and risk control.